Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5888_Библиотеки_им_академика_М_И_Перельмана
.pdf
52 M. G. Fabiano et al.
https://t.me/med1917
prepared from uncharged single-chain surfactants and cholesterol, whereas liposomes are prepared from double-chain phospholipids (neutral or charged) and
cholesterol. Surfactants can furthe r enhance the functions of the nanocarriers.
There are many cases where nanomecidines that are highly effective in vitro do
not work well in vivo because of unexpected problems that arise when applied to
humans.
Current information on surfactant vesicles is insufficient to overcome these
concerns. Therefore, continuing research is needed to obtain reliable information
in the future. Recently, advances in machine learning and artificial intelligence
allowed for the modelling of cell–nanomaterial interactions, enabling the prediction
of nanomedicine safety and efficacy (Singh et al. 2020; von Ranke et al. 2022).
As with liposomes, the in vitro/in vivo properties of nioso mes depend both on the
composition of the bilayer and on their method of production. Niosomal drug
delivery has yet to make its clinical debut, even though these systems have been
demonstrated to yield promising therapeutics. Niosomes alter the plasma clearance
kinetics, tissue distribution, metabolism, and cellular interaction of the drug. Despite
the many promising proof of concept studies, there is still a long road ahead for
niosomes to become a clinical reality. This means there are still many challenges that
need to be overcome, and there are still opportunities for academic and industrial
scientists to make a decisive impact.
References
Abdelbary G, El-Gendy N. Niosome-encapsulated gentamicin for ophthalmic controlled delivery.
AAPS PharmSciTech. 2008;9:740–7.
Abd-Elbary A, El-laithy HM, Tadros MI. Sucrose stearate-based proniosome-derived niosomes for
the nebulisable delivery of cromolyn sodium. Int J Pharm. 2008;357:189–98.
Abdelkader H, Ismail S, Kamal A, et al. Design and evaluation of controlled release niosomes and
discomes for naltrexone hydrochloride ocular delivery. J Pharm Sci. 2011;100:1833–46.
Abootorabi S, Akbari J, Saeedi M, et al. Atorvastatin entrapped noisome (atrosome): green
preparation approach for wound healing. AAPS PharmSciTech. 2022;23(3):81.
Aboubakr EM, Mohammed HA, Hassan AS, et al. Glutathione-loaded non-ionic surfactant
niosomes: a new approach to improve oral bioavailability and hepatoprotective efficacy of
glutathione. Nanotechnol Rev. 2021;11(1):117–37.
Ag Seleci D, Maurer V, Stahl F, et al. Rapid microfluidic preparation of niosomes for targeted drug
delivery. Int J Mol Sci. 2019;20(19):4696.
Aggarwal D, Kaur IP. Improved pharmacodynamics of timolol maleate from a mucoadhesive
niosomal ophthalmic drug delivery system. Int J Pharm. 2005;290:155–9.
Aggarwal D, Pal D, Mitra AK, et al. Study of the extent of ocular absorption of acetazolamide from
a developed niosomal formulation, by microdialysis sampling of aqueous humor. Int J Pharm.
2007;338:21–6.
Agrati C, Marianecci C, Sennato S, et al. Multicompartment vectors as novel drug delivery systems:
selective activation of Tγδ lymphocytes after zoledronic acid delivery. Nanomedicine. 2011;7:
153–61.
Akhter S, Kushwaha S, Warsi MH, et al. Development and evaluation of nanosized niosomal
dispersion for oral delivery of Ganciclovir. Drug Dev Ind Pharm. 2012;38:84–92.
3 Niosomes 53
https://t.me/med1917
Al Qtaish N, Gallego I, Villate-Beitia I, et al. Niosome-based approach for in situ gene delivery to
retina and brain cortex as immune-privileged tissues. Pharmaceutics. 2020;12(3):198.
Al Qtaish N, Gallego I, Paredes AJ, et al. Nanodiamond integration into niosomes as an emerging
and efficient gene therapy nanoplatform for central nervous system diseases. ACS Appl Mater
Interfaces. 2022;14(11):13665–77.
Alberts DS, Garcia DJ. Safety aspects of pegylated liposomal doxorubicin in patients with cancer.
Drugs. 1997;54:30–5.
Alonso MJ. Nanomedicines for overcoming biological barriers. Biomed Pharmacother. 2004;58:
168–72.
Ansari M, Eslami H. Preparation and study of the inhibitory effect of nano-niosomes containing
essential oil from artemisia absinthium on amyloid fibril formation. Nanomed J. 2020;7(3):
243–50.
Antunes FE, Gentile L, Rossi CO, et al. Gels of Pluronic F127 and nonionic surfactants from
rheological characterization to controlled drug permeation. Colloids Surf B Biointerfaces.
2011;87:42–8.
Apoorva A, Neha J, Gauree K, et al. Niosomes as targeted drug delivery systems. Int J Pharm Sci
Rev Res. 2012;12:53–60.
Arafa MG, Ayoub BM. Bioavailability study of niosomal salbutamol sulfate in metered dose
inhaler: controlled pulmonary drug delivery. J Aerosol Med Pulm Drug Deliv. 2018;31(2):1–2.
Arafa MG, Ghalwash D, El-Kersh DM, et al. Propolis-based niosomes as oromuco-adhesive films:
a randomized clinical trial of a therapeutic drug delivery platform for the treatment of oral
recurrent aphthous ulcers. Sci Rep. 2018;8(1):18056.
Aswin Jeno JG, Maria Packiam S, Nakkeeran E. Contact in-vivo larvicidal toxicity and histological
studies of Indian herb essential oils loaded niosomes against Aedes aegypti and Culex
quinquefasciatus (Diptera: Culicidae). Int J Trop Insect Sci. 2018;42(2):1373–87.
Attia N, Mashal M, Grijalvo S, et al. Stem cell-based gene delivery mediated by cationic niosomes
for bone regeneration. Nanomedicine. 2018;14(2):521–31.
Baillie AJ, Florence AT, Hume LR, et al. The preparation and properties of niosomes nonionic
surfactant vesicles. J Pharm Pharmacol. 1985;37:863–8.
Balzer D. Alkylpolyglucosides, their physico-chemical properties and their uses. Tenside Surf Det.
1991;28:419–27.
Bandak S, Ramu A, Barenholz Y, et al. Reduced UV-induced degradation of doxorubicin encap-
sulated in polyethyleneglycol-coated liposomes. Pharm Res. 1999;16:841–6.
Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of
swollen phospholipids. J Mol Biol. 1965;13:238–52.
Barenholz Y, Amselem S. Quality control assays in the development and clinical use of liposome-
based formulations. In: Gregoriadis G, editor. Liposome technology. 2nd ed. Boca Raton: CRC
Press; 1993.
Bayindir ZS, Yuksel N. Characterization of niosomes prepared with various nonionic surfactants
for paclitaxel oral delivery. J Pharm Sci. 2010;99:2049–60.
Bergstrand N, Arfvidsson MC, Kim JM, et al. Interactions between pH-sensitive liposomes and
model membranes. Biophys Chem. 2003;104:361–79.
Berry G, Billingham M, Alderman E, et al. The use of cardiac biopsy to demonstrate reduced
cardiotoxicity in AIDS Kaposi’s sarcoma patients treated with pegylated liposomal doxorubicin.
Ann Oncol. 1998;9:711–6.
Bhardwaj P, Niosomes: A review on niosomal research in the last decade. J Drug Deliv Technol.
2020;56101581. https://doi.org/10.1016/j.jddst.2020.101581
Binnig G, Rohrer H, Gerber C, et al. Surface studies by scanning tunneling microscopy. Phys Rev
Lett. 1982;49:57–61.
Blazek-Welsh AI, Rhodes DG. SEM imaging predicts quality of niosomes from maltodextrin-based
proniosomes. Pharm Res. 2001;18:656–661.
Boswell GW, Buell D, Bekersky I. Ambisome (Liposomal amphotericin B): a comparative review.
J Clin Pharmacol. 1998;38:583–92.
54 M. G. Fabiano et al.
https://t.me/med1917
Bragagni M, Mennini N, Ghelardini C, et al. Development and characterization of niosomal
formulations of Doxorubicin aimed at brain targeting. J Pharm Pharm Sci. 2012;15:184–96.
Brewer JM, Alexander J. The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the
BALB/c humoral response to bovine serum albumin. Immunology. 1992;75:570–5.
Caracciolo G, Pozzi D, Caminiti R, et al. Effect of hydration on the structure of solid-supported
Niosomal membranes investigated by in situ energy dispersive X-ray diffraction. Chem Phys
Lett. 2008;462:307–12.
Carafa M, Santucci E, Alhaique F, et al. Preparation and properties of new unilamellar non-ionic/
ionic surfactant vesicles. Int J Pharm. 1998;160:51–9.
Carafa M, Santucci E, Lucania G. Lidocaine-loaded non-ionic surfactant vesicles: characterization
and in vitro permeation studies. Int J Pharm. 2002;231:21–32.
Carafa M, Marianecci C, Lucania G, et al. New vesicular ampicillin-loaded delivery systems for
topical application: characterization, in vitro permeation experiments and antimicrobial activity.
J Control Release. 2004;95:67–74.
Carafa M, Di Marzio L, Marianecci C, et al. Designing novel pH-sensitive non-phospholipid
vesicle: characterization and cell interaction. Eur J Pharm Sci. 2006;28:385–93.
Carafa M, Marianecci C, Rinaldi F, et al. Span and Tween neutral and pH-sensitive vesicles:
characterization and in vitro skin permeation. J Liposome Res. 2009;19:332–40.
Chaudhari S, Chatur V. Development of valproic acid niosomal in situ nasal gel formulation for
epilepsy. Indian J Pharm Educ Res. 2013;47(3):31–41.
Chen WC, Juang RS, Wei YH. Applications of a lipopeptide biosurfactant, surfactin, produced by
microorganisms. Biochem Eng J. 2015;103:158–69.
Combalia J. Clinical trial to evaluate Papilocare® gel efficacy into repairment of cervical lesions
caused by HPV (PAPILOCAN)
Cooper AI. Synthesis and processing of polymers using supercritical carbon dioxide. J Mater Chem.
2000;10:207–34.
Cortesi R, Esposito E, Corradini F, et al. Non-phospholipid vesicles as carriers for peptides and
proteins: production, characterization and stability studies. Int J Pharm. 2007;339:52–60.
Cosco D, Paolino D, Muzzalupo R, et al. Novel PEG-coated niosomes based on bola-surfactant as
drug carriers for 5-fluorouracil. Biomed Microdevices. 2009;11:1115–25.
Davarpanah F, Khalili Yazdi A, Barani M, et al. Magnetic delivery of antitumor carboplatin by
using PEGylated-Niosomes. DARU J Pharm Sci. 2018;1:57–64.
De A, Venkatesh N, Senthil M, et al. Smart niosomes of temozolomide for enhancement of brain
targeting. Nanobiomedicine. 2018;1(5):184954351880535.
Del Burgo P, Aicart E, Junquera E. Mixed vesicles and mixed micelles of the cationic–cationic
surfactant system: didecyldimethylammonium bromide/dodecylethyldimethyl-ammonium bro-
mide/water. Colloids Surf A: Physicochem Eng Asp. 2007;292:165– 72.
Demir B, Barlas FB, Gumus ZP, et al. Theranostic niosomes as a promising tool for combined
therapy and diagnosis: “all-in-one” approach. ACS Appl Nano Mater. 2018;1(6):2827–35.
Di Marzio L, Marianecci C, Cinque B, et al. pH-sensitive non-phospholipid vesicle and
macrophage-like cells: binding, uptake and endocytotic pathway. Biochim Biophys Acta.
2008;1778:2749–56.
Di Marzio L, Marianecci C, Petrone M, et al. Novel pH-sensitive non-ionic surfactant vesicles:
comparison between Tween 21 and Tween 20. Colloids Surf B Biointerfaces. 2011;82:18–24.
Di Marzio L, Marianecci C, Rinaldi F, et al. Deformable surfactant vesicles loading ammonium
glycyrrhizinate: characterization and in vitro permeation studies. Lett Drug Des Discov. 2012;9:
494–9.
Di Marzio L, Esposito S, Rinaldi F, et al. Polysorbate 20 vesicles as oral delivery system: in vitro
characterization. Colloids Surf B: Biointerfaces. 2013;104:200–6.
Dipti S, Tyagi VK. Anionic gemini surfactants: a distinct class of surfactants. J Oleo Sci. 2006;55:
215–26.
Do Carmo MP. Differential geometry of curves and surfaces. New Jersey: Prentice-Hall; 1976.
ClinicalTrials.gov Identi fier: NCT04210336. 2019.
3 Niosomes 55
https://t.me/med1917
Dufes C, Gaillard F, Uchegbu IF, et al. Glucose-targeted niosomes deliver vasoactive intestinal
peptide (VIP) to the brain. Int J Pharm. 2004;285:77–85.
El-Laithy HM, Shoukry O, Mahran LG. Novel sugar esters proniosomes for transdermal delivery of
vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm. 2011;77:43–55.
El-Ridy MS, Abdelbary A, Nasr EA, et al. Niosomal encapsulation of the antitubercular drug,
pyrazinamide. Drug Dev Ind Pharm. 2011;37:1110–8.
Farajzadeh S, Ahmadi R, Mohammadi S, et al. Evaluation of the efficacy of intralesional
Glucantime plus niosomal zinc sulphate in comparison with intralesional Glucantime plus
cryotherapy in the treatment of acute cutaneous leishmaniasis, a randomized clinical trial. J
Parasit Dis. 2018a;42(4):616–20.
Farajzadeh S, Pardakhti A, Mohammadi S, et al. A randomized clinical trial of using niosomal zinc
sulfate plus cryotherapy in comparison with placebo along with cryotherapy in treatment of
common wart. J Kerman Univ Med Sci. 2018b;25:1–8.
Ferreira RR, Souza AG, Nunes LL, et al. Use of ball mill to prepare nanocellulose from eucalyptus
biomass: challenges and process optimization by combined method. Mater Today Commun.
2020;22:100755.
Foreman-Ortiz IU, Ma TF, Hoover BM, et al. Nanoparticle tracking analysis and statistical mixture
distribution analysis to quantify nanoparticle–vesicle binding. J Colloid Interface Sci. 2022;
J615:50–8.
Francis MF, Dhara G, Winnik FM, et al. In vitro evaluation of pH-sensitive polymer/niosome
complexes. Biomacromolecules. 2001;2:741–9.
Gabizon A, Goren D, Cohen R, et al. Development of liposomal anthracyclines: from basics to
clinical applications. J Control Release. 1998;53:275–9.
Gadapa S, Battula SN, Mor S, et al. Green tea catechin loaded niosomes: formulation and their
characterization for food fortification. J Food Sci Technol. 2022;59(9):3669–82.
García-Díaz M, Patiño B, Vázquez C, et al. A novel niosome-encapsulated essential oil formulation
to prevent Aspergillus flavus growth and aflatoxin contamination of maize grains during storage.
Toxins. 2019;11:646.
Ge X, Wei M, He S, et al. Advances of non-ionic surfactant vesicles (niosomes) and their
application in drug delivery. Pharmaceutics. 2019;11(2):55.
Ghode PP, Ghode S. Niosomes as modern drug carrier systems: concepts and advancements. Int J
Med Phar Sci. 2021;12:01–8.
Girigoswami A, Das S, De S. Fluorescence and dynamic light scattering studies of niosomes-
membrane mimetic systems. Spectrochim Acta A Mol Biomol Spectrosc. 2006;64:859–66.
Giunchedi P, Gavini E, Bonferoni MC. Nose-to-brain delivery. Pharmaceutics. 2020;12(2):138.
Goren D, Gabizon A, Barenholz Y. The influence of physical characteristics of liposomes
containing doxorubicin on their pharmacological behaviour. Biochim Biophys Acta.
1990;1029:285–94.
Gregoriadis G. Liposomes as drug carriers. New York: John Wiley and Sons; 1988.
Grijalvo S, Alagia A, Puras G, et al. Cationic nioplexes-in-polysaccharide-based hydrogels as
versatile biodegradable hybrid materials to deliver nucleic acids. J Mater Chem B. 2017;5
(37):7756–67.
Grijalvo S, Puras G, Zárate J, et al. Cationic niosomes as non-viral vehicles for nucleic acids:
challenges and opportunities in gene delivery. Pharmaceutics. 2019;11(2):50.
Gude RP, Jadhav MG, Rao SG, et al. Effects of niosomal cisplatin and combination of the same
with theophylline and with activated macrophages in murine B16F10 melanoma model. Cancer
Biother Radiopharm. 2002;17:183–92.
Gugleva V, Michailova V, Mihaylova R, et al. Formulation and evaluation of hybrid niosomal in
situ gel for intravesical co-delivery of curcumin and gentamicin sulfate. Pharmaceutics. 2022;14
(4):747.
Guinedi AS, Mortada ND, Mansour S, et al. Preparation and evaluation of reverse-phase evapora-
tion and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm. 2005;306:
71–82.
56 M. G. Fabiano et al.
https://t.me/med1917
Gupta NK, Dixit VK. Development and evaluation of vesicular system for curcumin delivery. Arch
Dermatol Res. 2011;303:89–101.
Gupta PN, Mishra V, Rawat A, et al. Non-invasive vaccine delivery in transfersomes, niosomes and
liposomes: a comparative study. Int J Pharm. 2005;293:73–82.
Hala SA-G, Sahar AM. Rectal dexmedetomidine niosomes for postoperative analgesia in pediatric
cancer patients. (DEX-NANO)
Handjani-Vila RM, Riber A, Rondot B, et al. Dispersions of lamellar phases of non-ionic lipids in
cosmetic products. Int J Cosmet Sci. 1979;1:303–14.
Hanieh PN, Forte J, Di Meo C, et al. Hyaluronic acid derivative effect on niosomal coating and
interaction with cellular mimetic membranes. Molecules. 2021;26(11):3434.
Haque F, Sajid M, Cameotra SS, et al. Anti-biofilm activity of a sophorolipid-amphotericin B
niosomal formulation against Candida albicans. Biofouling. 2017;33(9):768–79.
Haroun M, Elsewedy HS, Shehata TM, et al. Significant of injectable brucine PEGylated niosomes
in treatment of MDA cancer cells. J Drug Deliv Sci Technol. 2022;71:103322.
Harvey RD, Heenan RK, Barlow DJ, et al. The effect of electrolyte on the morphology of vesicles
composed of the dialkyl polyoxyethylene ether surfactant 2C18E12. Chem Phys Lipids.
2005;133:27–36.
Hashemi SMH, Enayatifard R, Akbari J, et al. Venlafaxine HCl encapsulated in niosome: green and
eco-friendly formulation for the management of pain. AAPS PharmSciTech. 2022;23(5):149.
Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. Physicochemical stability of colloidal lipid
particles. Biomaterials. 2003;24:4283–300.
Hong M, Zhu S, Jiang Y, et al. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated
niosomes modified with transferring. J Control Release. 2009;133:96–102.
Hood E, Gonzalez M, Plaas A, et al. Immuno-targeting of nonionic surfactant vesicles to inflam-
mation. Int J Pharm. 2007;339:222–30.
Horiuchi T, Tajima K. Supramolecular structure of functionality vesicles: niosome formation of
nonionic amphiphiles and physico-chemical properties in aqueous dispersion. J Jpn Oil Chem
Soc. 2000;49:1107–22.
Hu C, Rhodes DG. Proniosomes: a novel drug carrier preparation. Int J Pharm. 2000;206:110–22.
Huang Y, Chen J, Chen X, et al. PEGylated synthetic surfactant vesicles (Niosomes): novel carriers
for oligonucleotides. J Mater Sci Mater Med. 2008;19:607–14.
Huang Y, Rao Y, Chen J, et al. Polysorbate cationic synthetic vesicle for gene delivery. J Biomed
Mater Res Part A. 2011;96:513–9.
Hunter RJ. Foundations of colloid science. Oxford/New York: Oxford University Press; 1991.
Hunter CA, Dolan TF, Coombs GH, et al. Vesicular systems (niosomes and liposomes) for delivery
of sodium stibogluconate in experimental murine visceral leishmaniasis. J Pharm Pharmacol.
1988;40:161–5.
Imperlini E, Celia C, Cevenini A, et al. Nano-bio interface between human plasma and niosomes
with different formulations indicates protein corona patterns for nanoparticle cell targeting and
uptake. Nanoscale. 2021;13(10):5251–69.
Imura T, Gotoh T, Otake K, et al. Control of physicochemical properties of liposomes using a
supercritical reverse phase evaporation method. Langmuir. 2003;19:2021–5.
Israelachvili JN. Intermolecular and surface forces. 2nd ed. London: Academic Press; 1992.
Jadon PS, Gajbhiye V, Jadon RS, et al. Enhanced oral bioavailability of griseofulvin via niosomes.
AAPS PharmSciTech. 2009;10:1186–92.
Jain S, Singh P, Mishra V, et al. Mannosylated niosomes as adjuvant–carrier system for oral genetic
immunization against Hepatitis B. Immunol Lett. 2005;101:41–9.
Jatav VS, Singh SK, Khatri P, et al. Formulation and in-vitro evaluation of rifampicin-loaded
niosomes. J Chem Pharm Res. 2011;3:199–203.
Ji X, Gao Y, Chen L, et al. Nanohybrid systems of non-ionic surfactant inserting liposomes loading
paclitaxel for reversal of multidrug resistance. Int J Pharm. 2012;422:390–7.
ClinicalTrials.gov Identifier: NCT05340725. 2022.
3 Niosomes 57
https://t.me/med1917
Junyaprasert VB, Teeranachaideekul V, Supaperm T. Effect of charged and non-ionic membrane
additives on physicochemical properties and stability of niosomes. AAPS PharmSciTech.
2008;9:851–9.
Junyaprasert VB, Singhsa P, Suksiriworapong J, et al. Physicochemical properties and skin
permeation of Span 60/Tween 60 niosomes of ellagic acid. Int J Pharm. 2012;423:303–11.
Kaur IP, Aggarwal D, Singh H, et al. Improved ocular absorption kinetics of timolol maleate loaded
into a bioadhesive niosomal delivery system. Graefes Arch Clin Exp Ophthalmol. 2010;248:
1467–72.
Khallaf RA, Aboud HM, Sayed OM. Surface modified niosomes of olanzapine for brain targeting
via nasal route; preparation, optimization, and in vivo evaluation. J Liposome Res. 2020;30(2):
163–73.
Khosravi-Darani K, Pardakhty A, Honarpisheh H, et al. The role of high-resolution imaging in the
evaluation of nanosystems for bioactive encapsulation and targeted nanotherapy. Micron.
2007;38:804–18.
Kreuter J. Colloidal drug delivery system. New York: Marcel Dekker Inc; 1994.
Lakshmi PK, Bhaskaran S. Phase II study of topical niosomal urea gel- an adjuvant in the treatment
of psoriasis. Int J Pharm Sci Rev Res. 2011;7:1–7.
Lakshmi PK, Devi GS, Bhaskaran S, et al. Niosomal methotrexate gel in the treatment of localized
psoriasis: phase I and phase II studies. Indian J Dermatol Venereol Leprol. 2007;73:157–61.
Leelarungrayub J, Manorsoi J, Manorsoi A. Anti-inflammatory activity of niosomes entrapped with
Plai oil (Zingiber cassumunar Roxb.) by therapeutic ultrasound in a rat model. Int J
Nanomedicine. 2017;12:2469 –76.
Lentz BR. Use of fluorescent probes to monitor molecular order and motions within liposome
bilayers. Chem Phys Lipids. 1993;64:99–116.
Lentz BR, Carpenter T, Alford DR. Spontaneous fusion of phosphaticylcholine small unilamellar
vesicles in the fluid phase. Biochemistry. 1985;26:5389–97.
Lesieur S, Madelmont CT, Patenostre M, et al. Action of octylglucoside on nonionic monoalkyl
amphiphile-cholesterol vesicles study of the solubilization mechanism. Chem Phys Lipids.
1990;56:109–21.
Liu T, Guo R. Investigation of PEG 6000/Tween 80/Span 80/H2O niosome microstructure. Colloid
Polym Sci. 2007a;285:711–3.
Liu T, Guo R. Structure and transformation of the niosome prepared from PEG 6000/Tween
80/Span 80/H2O lamellar liquid crystal. Colloids Surf A: Physicochem Eng Asp. 2007b;295:
130–4.
Liu T, Guo R, Hua W, et al. Structure behaviors of hemoglobin in PEG 6000/Tween 80/Span
80/H2O niosome system. Colloids Surf A: Physicochem Eng Asp. 2007;293:255–26.
Lo CT, Jahn A, Locascio LE, et al. Controlled self-assembly of monodisperse niosomes by
microfluidic hydrodynamic focusing. Langmuir. 2010;26:8559–66.
Loh ZH, Samanta AK, Sia Heng PW. Overview of milling techniques for improving the solubility
of poorly water-soluble drugs. Asian J Pharm Sci. 2015;10(4):255–74.
Luciani A, Olivier JC, Clement O, et al. Glucose-receptor MR imaging of tumors: study in mice
with PEGylated paramagnetic niosomes. Radiology. 2004;231:135–42.
Macdonald AG, Wahle KWJ, Cossins AR, et al. Temperature, pressure and cholesterol effects on
bilayer fluidity – a comparison of pyrene excimer monomer ratios with the steady-state
fluorescence polarization of diphenylhexatriene in liposomes and microsomes. Biochim
Biophys Acta. 1988;938:231–42.
Machado ND, Silva OF, de Rossi RH, et al. Cyclodextrin modified niosomes to encapsulate
hydrophilic compounds. RSC Adv. 2018;8(52):29909–16.
Machado ND, García-Manrique P, Fernández MA, et al. Cholesterol free niosome production by
microfluidics: comparative with other conventional methods. Chem Eng Res Des. 2020;162:
162–71.
Maheshwari C, Pandey RS, Chaurasiya A, et al. Non-ionic surfactant vesicles mediated transcuta-
neous immunization against hepatitis B. Int Immunopharmacol. 2011;11:1516–22.
58 M. G. Fabiano et al.
https://t.me/med1917
Mahor S, Gupta PN, Rawat A, et al. A needle-free approach for topical immunization: antigen
delivery via vesicular carrier system(s). Curr Med Chem. 2007;14:2898–910.
Manconi M, Chiara S, Donatella V, et al. Niosomes as carriers for tretinoin I. Preparation and
properties. Int J Pharm. 2002;234:237–48.
Manconi M, Donatella V, Chiara S, et al. Niosomes as carriers for tretinoin II. Influence of vesicular
incorporation on tretinoin photostability. Int J Pharm. 2003;260:261 –72.
Manosroi A, Manosroi J. Microencapsulation of human insulin DEAE-dextran complex and the
complex in liposomes by the emulsion non-solvent addition method. J Microencapsul. 1997;14:
761–8.
Manosroi A, Wongtrakul P, Manosroi J, et al. Characterization of vesicles prepared with various
non-ionic surfactants mixed with cholesterol. Colloids Surf B Biointerfaces. 2003;30:129–38.
Manosroi A, Chutoprapat R, Abe M, et al. Characteristics of niosomes prepared by supercritical
carbon dioxide (scCO2) fluid. Int J Pharm. 2008a;352:248–55.
Manosroi A, Thathang K, Werner RG, et al. Stability of luciferase plasmid entrapped in cationic
bilayer vesicles. Int J Pharm. 2008b;356:291–9.
Manosroi A, Jantrawut P, Manosroi J. Anti-inflammatory activity of gel containing novel elastic
niosomes entrapped with diclofenac diethylammonium. Int J Pharm. 2008c;360:156–63.
Manosroi A, Khositsuntiwong N, Götz F, et al. Transdermal enhancement through rat skin of
luciferase plasmid DNA loaded in elastic nanovesicles. J Liposome Res. 2009;19:91–8.
Manosroi A, Khanrin P, Lohcharoenkal W, et al. Transdermal absorption enhancement through rat
skin of gallidermin loaded in niosomes. Int J Pharm. 2010;392:304–10.
Manosroi J, Lohcharoenkal W, Götz F, et al. Transdermal absorption enhancement of N-terminal
Tat–GFP fusion protein (TG) loaded in novel low toxic elastic anionic niosomes. J Pharm Sci.
2011;100:1525–34.
Manrique P, Machado ND, Fernández MA, et al. Effect of drug molecular weight on niosomes size
and encapsulation efficiency. Colloids Surf B: Biointerfaces. 2020;186:110711.
Marianecci C, Paolino D, Celia C, et al. Non-ionic surfactant vesicles in pulmonary glucocorticoid
delivery: characterization and interaction with human lung fibroblasts. J Control Release.
2010;147:127–35.
Marianecci C, Carafa M, Di Marzio L, et al. A new vesicle-loaded hydrogel system suitable for
topical applications: preparation and characterization. J Pharm Pharm Sci. 2011;14:336–46.
Marianecci C, Rinaldi F, Mastriota M, et al. Anti-inflammatory activity of novel ammonium
glycyrrhizinate/niosomes delivery system: human and murine models. J Control Release.
2012;164:17–25.
Marianecci C, Di Marzio L, Rinaldi F, et al. Niosomes from 80s to present: the state of the art. Adv
Colloid Interf Sci. 2014;205:187–206.
Marianecci C, Di Marzio L, Del Favero E, et al. Niosomes as drug nanovectors: multiscale
pH-dependent structural response. Langmuir. 2016;32(5):1241–9.
Mashal M, Attia N, Soto-Sánchez C, et al. Non-viral vectors based on cationic niosomes as efficient
gene delivery vehicles to central nervous system cells into the brain. Int J Pharm. 2018;552
(1–2):48–55.
Masotti A, Vicennati P, Alisi A, et al. Novel Tween 20 derivatives enable the formation of efficient
pH-sensitive drug delivery vehicles for human hepatoblastoma. Bioorg Med Chem Lett.
2010;20:3021–
Mehta SK, Jindal N, Kaur G. Quantitative investigation, stability and in vitro release studies of anti-
TB drugs in Triton niosomes. Colloids Surf B Biointerfaces. 2011;87:173–9.
Menger FM, Littau CA. Gemini surfactants: a new class of self-assembling molecules. J Am Chem
Soc. 1993;115:10083–90.
Moazeni E, Gilani K, Sotoudegan F, et al. Formulation and in vitro evaluation of ciprofloxacin
containing niosomes for pulmonary delivery. J Microencapsul. 2010;27:618 –27.
Mohammadi S, Mohebbi A. A survey to compare the efficacy of niosomal erythromycin alone
versus combination of erythromycin and zinc acetate in the treatment of acne vulgaris. J Kerman
Univ Med Sci. 2017;24(5):12.
5.
3 Niosomes 59
https://t.me/med1917
Mohanty A, Dey J. Enantioselectivity of vesicle-forming chiral surfactants in capillary electropho-
resis: role of the surfactant headgroup structure. J Chromatogr A. 2006;1128:259–66.
Momekova DB, Gugleva VE, Petrov PD. Nanoarchitectonics of multifunctional niosomes for
advanced drug delivery. ACS Omega. 2021;6:33265–73.
Morigaki K, Walde P. Fatty acid vesicles. Curr Opin Colloid Interface Sci. 2007;12:75–80.
Mozafari MR. Liposomes: an overview of manufacturing techniques. Cell Mol Biol Lett. 2005a;10:
711–9.
Mozafari MR. Method and apparatus for producing carrier complexes. UK Patent. 2005b.
Mozafari MR, Mortazavi SM. Nanoliposomes: from fundamentals to recent developments. Oxford:
Trafford Publishing Ltd; 2005.
Mozafari MR, Reed CJ, Rostron C, et al. Construction of stable anionic liposome-plasmid particles
using the heating method: a preliminary investigation. Cell Mol Biol Lett. 2002;7:923–7.
Mozafari MR, Reed CJ, Rostron C. Cytotoxicity evaluation of anionic nanoliposomes and
nanolipoplexes prepared by the heating method without employing volatile solvents and
detergents. Pharmazie. 2007;62:205–9.
Müller R. Carriers for controlled drug delivery and targeting. Boca Raton: CRC Press; 1991.
Müller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy.
Rationale for development and what we can expect for the future. Adv Drug Deliv Rev.
2001;47:3–19.
Muzzalupo R, Ranieri GA, La Mesa C. Translational diffusion and other physicochemical proper-
ties of a bolaform surfactant in solution. Langmuir. 1996;12:3157–61.
Muzzalupo R, Trombino S, Iemma F, et al. Preparation and characterization of bolaform surfactant
vesicles. Colloids Surf B Biointerfaces. 2005;46:78–83.
Muzzalupo R, Nicoletta FP, Trombino S, et al. A new crown ether as vesicular carrier for
5-fluoruracil: synthesis, characterization and drug delivery evaluation. Colloids Surf B
Biointerfaces. 2007;58:197– 202.
Muzzalupo R, Tavano L, Trombino S, et al. Niosomes from α,ω-trioxyethylene-bis(sodium
2-dodecyloxy-propylenesulfonate): preparation and characterization. Colloids Surf B
Biointerfaces. 2008;64:200– 7.
Namani T, Ishikawa T, Morigaki K, et al. Vesicles from docosahexaenoic acid. Colloids Surf B
Biointerfaces. 2007;54:118– 23.
Nasseri B. Effect of cholesterol and temperature on the elastic properties of niosomal membranes
International J Pharm. 2005;300(1-2) 95-101.
Nasr M. In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration.
AAPS PharmSciTech. 2010;11:85–9.
New RRC. Introduction and preparation of liposomes. In: New RRC, editor. Liposomes: a practical
approach. 1st ed. Oxford: Oxford University Press; 1990.
Otake K, Imura T, Sakai H, et al. Development of a new preparation method of liposomes using
supercritical carbon dioxide. Langmuir. 2001;17:3898–901.
Paolino D, Cosco D, Muzzalupo R, et al. Innovative bola-surfactant niosomes as topical delivery
systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharm. 2008;353:233–42.
Pham TT, Jaafar-Maalej C, Charcosset C, et al. Liposome and niosome preparation using a
membrane contactor for scale-up. Colloids Surf B Biointerfaces. 2012;94:5–21.
Platz G, Thunig C, Pőlicke J, et al. Phase-behavior of alkyl polyglucosides in combination with fatty
alcohols and alkyl sulphates. Colloids Surf A: Physicochem Eng Asp. 1994;88:113–22.
Pozzi D, Caminiti R, Marianecci C, et al. Effect of cholesterol on the formation and hydration
behavior of solid- supported niosomal membranes. Langmuir. 2010;26:2268–73.
Renouf P, Mioskowski C, Lebeau L, et al. Dimeric surfactants: first synthesis of an asymmetrical
gemini compound. Tetrahedron Lett. 1998;39:1357–60.
Renouf P, Hebrault D, Desmurs JR, et al. Synthesis and surface-active properties of a series of new
anionic gemini compounds. Chem Phys Lipids. 1999;99:21–
Rinaldi F, Hanieh P, Chan L, et al. Chitosan glutamate-coated niosomes: a proposal for nose-to-
brain delivery. Pharmaceutics. 2018;10(2):38.
https://doi.org/10.1016/j.ijpharm.2005.05.009
32.
60 M. G. Fabiano et al.
https://t.me/med1917
Rinaldi F, Del Favero E, Moeller J, et al. Hydrophilic silver nanoparticles loaded into niosomes:
physical–chemical characterization in view of biological applications. Nanomaterials. 2019a;9:
1177.
Rinaldi F, Seguella L, Gigli S, et al. Pentasomes: an innovative nose-to-brain pentamidine delivery
blunts MPTP parkinsonism in mice. J Control Release. 2019b;294:17–26.
Rinaldi F, Hanieh PN, Imbriano A, et al. Different instrumental approaches to understand the
chitosan coated niosomes/mucin interaction. J Drug Deliv Sci Technol. 2020;55:101339.
Rogerson A, Cummings J, Willmott N, et al. The distribution of doxorubicin in mice following
administration in niosomes. J Pharm Pharmacol. 1988;40:337–42.
Rolland A. Pharmaceutical particulate carriers. New York: Marcel Dekker; 1993.
Roy S, Dey J. Effect of hydrogen-bonding interactions on the self-assembly formation of sodium
N-(11-acrylamidoundecanoyl)-l-serinate, l-asparaginate, and l-glutaminate in aqueous solution.
J Colloid Interface Sci. 2007;307:229–34.
Sabareesh M, Yanadaiah JP, Chandrasekhar KB. Novel nanoproniosomal vesicular carriers for the
effective and efficient drug delivery: fundamentals, recent advancements and applications. Res J
Pharm Technol. 2021;14(11):6155–65.
Saettone MF, Perini G, Carafa M, et al. Non-ionic surfactant vesicles as ophthalmic carriers for
cyclopentolate a preliminary evaluation. STP Pharma Sci. 1996;6:94–8.
Saman Y, Yasamineh P, Kalajahi HG, et al. A state-of-the-art review on the recent advances of
niosomes as a targeted drug delivery system. Int J Pharm. 2022;624:121878.
Santucci E, Carafa M, Coviello T, et al. Vesicles from polysorbate-20 and cholesterol-a simple
preparation and a characterization. STP Pharma Sci. 1996;6:29–32.
Sarkar S, Mandal S, Sinha J, et al. Quercetin: critical evaluation as an antileishmanial agent in vivo
in hamsters using different vesicular delivery modes. J Drug Target. 2002;10:573–8.
Sarubbo LA, Silva MDGC, Durval IJB, et al. Biosurfactants: production, properties, applications,
trends, and general perspectives. Biochem Eng J. 2022;181:108377.
Sathali AAH, Rajalakshmi G. Evaluation of transdermal targeted niosomal drug delivery of
terbinafine hydrochloride. Int J Pharmtech Res. 2010;2:2081–9.
Schukin ED, Amelina EA. Contact interactions in disperse systems. Adv Colloid Interf Sci.
1979;11:235–87.
Sennato S, Bordi F, Cametti C, et al. Hybrid niosome complexation in the presence of oppositely
charged polyions. J Phys Chem B. 2008;112:3720–7.
Shi B, Fang C, Pei Y. Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle
size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharma-
cokinetics and antitumor activity. J Pharm Sci. 2006;95:1873–87.
Simons K, Ikonen E. How cells handle cholesterol. Science. 2000;290:721–1725.
Sinclair GW, Peppas NA. Analisys of non-fickian transport polymers using simplified exponential
expression. J Membr Sci. 1984;17:329–31.
Singh P, Prabakaran D, Jain S, et al. Cholera toxin B subunit conjugated bile salt stabilized vesicles
(bilosomes) for oral immunization. Int J Pharm. 2004;278:379 –90.
Singh AV, Ansari MHD, Rosenkranz D, et al. Artificial intelligence and machine learning in
computational nanotoxicology: unlocking and empowering nanomedicine. Adv Healthc
Mater. 2020;9:1901862.
Sita VG, Jadhav D, Vavia P. Niosomes for nose-to-brain delivery of bromocriptine: formulation
development, efficacy evaluation and toxicity profiling. J Drug Deliv Sci Technol. 2020;58:
101791.
Tabbakhian M, Tavakoli N, Jaafari MR, et al. Enhancement of follicular delivery of finasteride by
liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster
flank and ear models. Int J Pharm. 2006;323:1–10.
Tanford C. The hydrophobic effect. New York: Wiley; 1980.
Temprom L, Krongsuk S, Thapphasaraphong S, et al. A novel preparation and characterization of
melatonin loaded niosomes based on using a ball milling method. Mater Today Commun.
2022;31:103340.
3 Niosomes 61
https://t.me/med1917
Terzano C, Allegra L, Alhaique F, et al. Non-phospholipid vesicles for pulmonary glucocorticoid
delivery. Eur J Pharm Biopharm. 2005;59:57–62.
Trinh LH, Takzare A, Ghafoor DD, et al. Trachyspermum copticum essential oil incorporated
niosome for cancer treatment. J Drug Deliv Sci Technol. 2019;52:818–24.
Tsuchihashi M, Harashima H, Kiwada H. Development of a pharmacokinetic/pharmacodynamic
(PK/PD)-simulation system for doxorubicin in long circulating liposomes in mice using perito-
neal P388. J Control Release. 1999;61:9–19.
Uchegbu IF, Florence AT. Nonionic surfactant vesicles (niosomes) physical and pharmaceutical
chemistry. Adv Colloid Interf Sci. 1995;58:1–55.
Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm.
1998;172:33–70.
Vangala A, Kirby D, Rosenkrands I et al. A comparative study of cationic liposome and niosome-
based adjuvant systems for protein subunit vaccines: characterisation environmental scanning
electron microscopy and immunisation studies in mice Abstract. J Pharm Pharmacol. 2006;58
(6) 787–799.
van Hal DA, Bouwstra JA, Van Rensen A, et al. Preparation and characterization of nonionic
surfactant vesicles. J Colloid Interface Sci. 1996;178:263–73.
Vanlerberghe G, Morancais JL. Niosomes in perspective. STP Pharma Sci. 1996;1:5–11.
Von Ranke NL, Geraldo RB, Lima dos Santos A, et al. Applying in silico approaches to
nanotoxicology: current status and future potential. Comput Toxicol. 2022;22:100225.
Vyas SP, Singh RP, Jain S, et al. Non-ionic surfactant based vesicles (niosomes) for non-invasive
topical genetic immunization against hepatitis B. Int J Pharm. 2005;296:80–6.
Wieprecht T, Beyermann M, Seelig J. Thermodynamics of the coil–α-helix transition of amphi-
pathic peptides in a membrane environment: the role of vesicle curvature. Biophys Chem.
2002;96:191–201.
Xue Y, Gao Q, Zhang L. Extended ocular delivery of latanoprost from niosome-laden contact
lenses: in vitro characterization and in vivo studies. J Drug Deliv Sci Technol. 2022;68:103044.
Yang C, Gao S, Song P, Dagnæs-Hansen F, et al. Theranostic niosomes for efficient siRNA/
microRNA delivery and activatable near-infrared fluorescent tracking of stem cells. ACS Appl
Mater Interfaces. 2018;10(23):19494–503.
Yoshida H, Lehr CM, Kok W, et al. Niosomes for oral delivery of peptide drugs. J Control Release.
1992;21:145–53.
Zana R. Physicochemical properties of dimeric surfactants in aqueous solution. In: Esumi K,
Ueno M, editors. Structure-performance relationships in surfactants. 1st ed. New York: Marcel
Dekker; 1997.
Zareie MH, Mozafari MR, Hasirci V, et al. Scanning tunnelling microscopy investigation of
liposome-DNA-Ca2+ complexes. J Liposome Res. 1997;7:491–502.
Zhai L, Lu X, Chen W, et al. Interaction between spontaneously formed SDBS/CTAB vesicles
and polymer studied by fluorescence method. Colloids Surf A: Physicochem Eng Asp.
2004;236:1–5.
https://doi.org/10.1211/jpp.58.6.0009
Соседние файлы в папке Библиотека им академика М.И. Перельмана